OOIR: Observatory of International Research

Papers

(The median citation count of Cancer Journal is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
PET Imaging of Metabolism, Perfusion, and Hypoxia	63
Social Drivers of Cancer Risk and Outcomes Among African American Men	43
Oncology Physician Workforce Diversity	34
Toxicities From Antibody-Drug Conjugates	20
HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer	19
Poly(ADP-Ribose) Polymerase Inhibitor Inhibition in Ovarian Cancer	19
Individualizing Therapy for Malignant Gliomas	17
Building a Bridge to Equity in Health and Health Care in Cancer Care	15
Clinical Evidence Generation During a Pandemic	15
Introduction Chronic Lymphocytic Leukemia. Where Do We Stand, Where Do We Go	15
Nonoperative Management for Rectal Cancer	14
Health Care Policy and Disparities in Health	14
Stereotactic Body Radiation Therapy	14
c-Met Signaling as a Therapeutic Target in Head and Neck Cancer	14
Measurable Residual Disease Assessment as a Surrogate Marker in New Drug Development in Acute Myeloid Leukemia	13
Therapeutic Response Assessment of High-Grade Gliomas During Early-Phase Drug Development in the Era of Molecular and Immunotherapies	12
The Principles and Practice of PARP Inhibitor Therapy	12
Melanoma—Modern Treatment for Metastatic Melanoma	11
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes	11
Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy	11
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer	11
Clinical Targeting of Altered Metabolism in High-Grade Glioma	11
Primary Prevention of Cancer	10
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma	10
Metastatic Melanoma Treatment in Special Populations	10

Antibody Drug Conjugates in Multiple Myeloma	9
Germline Predisposition to Myelodysplastic Syndromes	9
Prostate Cancer, Race, and Health Disparity	9
Diversity in Cancer Care	9
Overlooked and Damaging Impact of Structural Racism and Implicit Bias on US Health Care	8
Aurora Kinases as Therapeutic Targets in Head and Neck Cancer	8
DNA Damage Repair Inhibitors—Combination Therapies	7
Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes	7
Advanced Imaging and Computational Techniques for the Diagnostic and Prognostic Assessment of Malignant Gliomas	7
Rectal Cancer—The Only Constant Is Change	7
Updates in the Management of Uveal Melanoma	7
Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality-of-Life Outcomes in Previously Untreated Patients With Nonsquamous Non–Small Cell Lung Cancer	7
Current State of Neoadjuvant Therapy for Locally Advanced Rectal Cancer	7
Overview of the Management of Higher-Risk Myelodysplastic Syndromes	7
Are We Witnessing a Paradigm Shift in the Treatment of Acute Myeloid Leukemia?	7
How We Incorporate Venetoclax in Treatment Regimens for Acute Myeloid Leukemia	7
Menopausal Hormone Therapy and Breast Cancer	6
Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era	6
Impact of Precision Medicine in Oncology	6
The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer	6
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic Disease	6
Supportive Care for Patients With Myelodysplastic Syndromes	6
New Metabolomic Insights Into Cancer	6
Role of the Microbiome in Immunotherapy of Melanoma	6
How Far We’ve Come	6
PI3K Inhibition for Squamous Cell Head and Neck Carcinoma	6
Advances in Stereotactic Body Radiation Therapy for Lung Cancer	6
The Clinical Challenges, Trials, and Errors of Combatting Poly(ADP-Ribose) Polymerase Inhibitors Resistance	6
Neurosurgical Advances for Malignant Gliomas	6
Evolving Landscape of Antibody Drug Conjugates in Lymphoma	6
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments	6
Telehealth and Technology	5
Telemedicine Across the Cancer Care Continuum	5
Survival of the Fittest	5
Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms	5
Introduction	5
Discovery of Natural Products for Cancer Prevention	5
Telemedicine and cancer care: Barriers and strategies to optimize delivery: Erratum	5
What Role Does Radiotherapy Play in the Molecular Era for Intrahepatic Cholangiocarcinoma?	5
The Lung Microbiome in Carcinogenesis and Immunotherapy Treatment	5
Evolution of Therapy for Older Patients With Acute Myeloid Leukemia	5
Hormone Replacement Therapy After Breast Cancer	5
The Challenges and Future of Immunotherapy for Gliomas	5
Current State of Cell Therapies for Genitourinary Malignancies	5
Estrogen for the Treatment and Prevention of Breast Cancer	5
Gene Expression Profiles in Cancers and Their Therapeutic Implications	4
Molecular Imaging of Steroid Receptors in Breast Cancer	4
With Our Powers Combined	4
Diagnostic and Therapeutic Application of Fibroblast Activation Protein Inhibitors in Oncologic and Nononcologic Diseases	4
Individual Benefits and Risks of Intravaginal Estrogen and Systemic Testosterone in the Management of Women in the Menopause, With a Discussion of Any Associated Risks for Cancer Development	4

What to Eat for Cancer Prevention	4
Telemedicine and Cancer Care	4
The Gut Microbiome and Pancreatic Cancer Development and Treatment	4
Recent Advances in Blood-Based Liquid Biopsy Approaches in Prostate Cancer	4
STING Agonists in Head and Neck Squamous Cell Carcinoma	4
Repurposing Drugs for Cancer Prevention	4
Impact of Precision Medicine in Oncology	4
The Microbiome and Its Impact on Allogeneic Hematopoietic Cell Transplantation	4
Concerns About Compounded Bioidentical Menopausal Hormone Therapy	3
Introduction	3
PARP Inhibitors in Pancreatic Cancer	3
Radiopharmaceuticals for Cancer Diagnosis and Therapy	3
Severe Lymphopenia Predicts Poorer Survival in Patients With Rectal Cancer Undergoing Neoadjuvant Chemoradiation	3
Chimeric Antigen Receptor T-Cell Therapy	3
Updates in Classification of Myelodysplastic Syndrome	3
Adoptive Cell Therapy for Advanced Solid Tumors	3
Management of Low-Grade Gliomas	3
Advancements in Understanding and Preventing Obesity-Related Colon Cancer	3
Local Excision for Early-Stage Rectal Adenocarcinomas	3
Beyond the COVID-19 Pandemic	3
Is There a Role for Cellular Therapy in Chronic Lymphocytic Leukemia?	3
Circulating Biomarkers in Glioblastoma	3
Epidemiology and Pathogenesis of Myelodysplastic Syndrome	3
Menin Inhibitors in Acute Myeloid Leukemia—What Does the Future Hold?	3
Evolution of Response-Based Radiotherapy for Hepatocellular Cancer	3
Antibody-Drug Conjugates in Myeloid Leukemias	3
The Clinical Value of Plasma Epstein-Barr Virus DNA as a Tumor Marker in Nasopharyngeal Carcinoma: Prognostic? Yes, But How Can We Best Use It?	3
Precision Radiotherapy for Gliomas	2
Checkpoint Inhibitors and Other Immune-Based Therapies in Acute Myeloid Leukemia	2
Digital Health for Oncological Care	2
Telemedicine and Burnout—How Enhancing Operational Support Can Improve Digital Health Tools	2
PARP Inhibition in Advanced Prostate Cancer	2
The Menopause Management Vacuum	2
Mining the Microenvironment for Therapeutic Targets in Chronic Lymphocytic Leukemia	2
Preclinical In Vitro and In Vivo Models for Adoptive Cell Therapy of Cancer	2
Treatment of Stage III Resectable Melanoma—Adjuvant and Neoadjuvant Approaches	2
Effective Image Communication of Hormone Replacement Therapy Risks and Benefits	2
The Management of Low-Risk Myelodysplastic Syndromes—Current Standards and Recent Advances	2
Fecal Microbiota Transplantation as a Cancer Therapeutic	2
Shifting the Landscape of Spine and Non-Spine Bone Metastases	2
Targets for Cancer Prevention: Evolving Methodologies in Basic and Epidemiological Sciences Identify Interrelated Pathways and the Need for Holistic Approaches	2
The Role of Circulating Tumor DNA for Management of Patients With Rectal Cancer	2
Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 Vaccine	2
DNA Damage Response in Glioblastoma	2
The Evolving Role of Allogeneic Stem Cell Transplant in the Era of Molecularly Targeted Agents	2
Nuclear Medicine Cancer Care—Current Status and Future Directions for Radiopharmaceutical Diagnostics and Theranostics for Cancer	2
Stereotactic Body Radiotherapy in Oligomestatic/Oligoprogressive Sarcoma	2
The Utility of Interim Positron Emission Tomography Imaging to Inform Adaptive Radiotherapy for Head and Neck Squamous Cell Carcinoma	2
Antibody-Drug Conjugates and Tissue-Agnostic Drug Development	2
Diversity and Disparities in Lung Cancer Outcomes Among Minorities	2
Monoclonal Antibodies in Acute Myeloid Leukemia—Are We There Yet?	2
The Promise of Cancer Health Justice	2
Neoantigen-Specific T Cells in Adoptive Cell Therapy	2